Evidence map›Paper›PMID 37483182›Full record

ArticleACS omega2023

Hybrid Controller Based on Numerical Methods for Chemical Processes with a Long Time Delay.

Marco Herrera, Diego Benítez, Noel Pérez-Pérez, Antonio Di Teodoro, Oscar Camacho

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 16 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marco HerreraColegio de Ciencias e Ingenierías "El Politécnico", Universidad San Francisco de Quito USFQ, Quito 170157, Ecuador.
Diego BenítezColegio de Ciencias e Ingenierías "El Politécnico", Universidad San Francisco de Quito USFQ, Quito 170157, Ecuador.
Noel Pérez-PérezColegio de Ciencias e Ingenierías "El Politécnico", Universidad San Francisco de Quito USFQ, Quito 170157, Ecuador.ORCID https://orcid.org/0000-0003-3166-745X
Antonio Di TeodoroColegio de Ciencias e Ingenierías "El Politécnico", Universidad San Francisco de Quito USFQ, Quito 170157, Ecuador.
Oscar CamachoColegio de Ciencias e Ingenierías "El Politécnico", Universidad San Francisco de Quito USFQ, Quito 170157, Ecuador.ORCID https://orcid.org/0000-0001-8827-5938
Universidad San Francisco de Quito · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hybrid control framework is proposed as an alternative for long time delays in chemical processes. The hybrid approach mixes the numerical methods in an internal mode control (IMC) structure, which uses the particle swarm optimization (PSO) algorithm to improve the adjustment of the controller parameters. Simulation tests are carried out on linear systems of high order and inverse response, both with dominant delay, and tests on a nonlinear process (chemical reactor). The performance of the proposed controller is stable and satisfactory despite nonlinearities in various operating conditions, set-point changes, process disturbances, and modeling errors. In addition, experimental tests were performed on a setup composed of two heaters and two temperature sensors mounted on an Arduino microcontroller-based board called the Temperature Control Laboratory (TCLab), with an additional software delay introduced. The merits and drawbacks of each scheme are analyzed using radar charts, comparing the control methods with different performance measures for set-point and disturbance changes. Furthermore, the new controller uses PSO to improve the tuning parameters.

Identifiers

PMID37483182
PMCPMC10357567
OpenAlexW4383498065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.